Medtech Acquisition Corp Valuation
| MTACUDelisted Stock | USD 9.86 0.00 0.00% |
At this time, the firm appears to be overvalued. Medtech Acquisition Corp secures a last-minute Real Value of $8.47 per share. The latest price of the firm is $9.86. Our model forecasts the value of Medtech Acquisition Corp from analyzing the firm fundamentals such as Net Income of 5.54 M, return on asset of -0.0193, and Price To Earning of 39.61 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Medtech Acquisition's price fluctuation is very steady at this time. Calculation of the real value of Medtech Acquisition Corp is based on 3 months time horizon. Increasing Medtech Acquisition's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Medtech Acquisition's intrinsic value may or may not be the same as its current market price of 9.86, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.86 | Real 8.47 | Hype 9.86 |
The intrinsic value of Medtech Acquisition's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medtech Acquisition's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medtech Acquisition Corp helps investors to forecast how Medtech stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medtech Acquisition more accurately as focusing exclusively on Medtech Acquisition's fundamentals will not take into account other important factors: Medtech Acquisition Total Value Analysis
Medtech Acquisition Corp is now forecasted to have takeover price of 81.09 M with market capitalization of 306.25 M, debt of 2.37 M, and cash on hands of 69.18 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medtech Acquisition fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
81.09 M | 306.25 M | 2.37 M | 69.18 K |
Medtech Acquisition Asset Utilization
One of the ways to look at asset utilization of Medtech is to check how much profit was generated for every dollar of assets it reports. Medtech Acquisition Corp secures a negative usage of assets of -0.0193 %, losing $1.93E-4 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Medtech Acquisition Corp shows how discouraging it operates for each dollar spent on its assets.Medtech Acquisition Profitability Analysis
Net Income was 5.54 M with profit before overhead, payroll, taxes, and interest of 0.About Medtech Acquisition Valuation
The delisted stock valuation mechanism determines Medtech Acquisition's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Medtech Acquisition Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medtech Acquisition. We calculate exposure to Medtech Acquisition's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medtech Acquisition's related companies.MedTech Acquisition Corporation does not have significant operations. The company was incorporated in 2020 and is based in Greenwich, Connecticut. Medtech Acquisition is traded on NASDAQ Exchange in the United States.
Medtech Acquisition Growth Indicators
Investing in growth stocks can be very risky. If the company such as Medtech Acquisition does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 31.2 M | |
| Quarterly Earnings Growth Y O Y | -0.646 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |